Thrombophilia is a predisposition to the formation of thrombosis. Its cause may be inherited or acquired.
1) Inherited causes of thrombophilia include:
1) Inherited causes of thrombophilia include:
- Protein C deficiency
- Protein S deficiency
- Antithrombin deficiency
- Activated protein C resistance
- Factor V Leiden (see below)
- Homocysteinuria
- cancer
- pregnancy
- eostrogen therapy
- sickle cell disease
- thrombotic thrombocytopenic purpura (see below)
- nephrotic syndrome
- antiphospholipid antibodies
Factor V Leiden
A point mutation on the gene for clotting factor V results in a variant known as 'factor V Leiden'.
The result of this mutation is that factor V is insensitive to protein C inactivation, resulting in hypercoagulabilty and hence increased risk of PEs/DVTs and even Budd Chiari syndrome.
Factor V Leiden is inherited in an autosomal dominant fashion with incomplete penetrance.
Thrombotic thrombocytopenic purpura
Thrombotic thrombocytopenic purpura is a condition in which systemic thrombi develop formed of platelets and Von Willebrand factor
The 5 key features are:
- Thrombocytopenic purpura
- Microangiopathic haemolytic anaemia
- Renal failure
- Fever
- Fluctuating neurological dysfunction
Thrombotic thrombocytopenic purpura may be either:
- Congenital = mutation of ADAMTS13 allelle (AKA Upshaw-Schulman syndrome)
- Acquired = autoantibodies against ADAMTS13
Adult females are most commonly affected
Treatment is:
- Plasma exchange
- Second line therapies include: vincristine, splenectomy, cyclosporine, azothioprine
- Possibly rituximab
Without treatment mortality is around 90%; with treatment mortality decreases to 10%.
References:
Bertina, R. Factor V Leien and other coagulation factor mutations affecting thrombotic risk. Clin Chem. 1997; 43(9): 1678-1683.
Galbusera, M., Noris, M. and Remuzzi, G. Inherited thrombotic thrombocytopenic purpura. Haemtologica. 2009; 94(2): 166-170.
Han-Mou, T. Current concepts in thrombotic thrombocytopenic purpura. Annu Rev Med. 2006; 57: 419-436.
Han-Mou, T. Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hamatol. 2010; 91(1): 1-19.
Helt, J. Thrombophilia: common questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program. 2007: 127-135.
Bertina, R. Factor V Leien and other coagulation factor mutations affecting thrombotic risk. Clin Chem. 1997; 43(9): 1678-1683.
Galbusera, M., Noris, M. and Remuzzi, G. Inherited thrombotic thrombocytopenic purpura. Haemtologica. 2009; 94(2): 166-170.
Han-Mou, T. Current concepts in thrombotic thrombocytopenic purpura. Annu Rev Med. 2006; 57: 419-436.
Han-Mou, T. Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hamatol. 2010; 91(1): 1-19.
Helt, J. Thrombophilia: common questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program. 2007: 127-135.